Evidence map›Paper›PMID 35640931›Full record

ArticleJournal for immunotherapy of cancer2022

Response to: Correspondence on 'Novel imaging biomarkers predict outcomes in stage III unresectable non-small cell lung cancer treated with chemoradiation and durvalumab' by Zheng

Vidya Sankar Viswanathan, Mohammadhadi Khorrami, Khalid Jazieh, Pingfu Fu, Nathan Pennell, Anant Madabhushi

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal for immunotherapy of cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Vidya Sankar ViswanathanDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio, USA.
Mohammadhadi KhorramiBiomedical Engineering, Case Western Reserve Univ, Cleveland, Ohio, USA.
Khalid JaziehDepartment of Internal Medicine, Cleveland Clinic, Cleveland, Ohio, USA.
Pingfu FuPopulation and Quantitattive Health Sciences, Case Western Reserve University, Cleveland, Ohio, USA.
Nathan PennellDepartment of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, USA.ORCID 0000-0002-1458-0064
Anant MadabhushiDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio, USA axm788@case.edu.ORCID 0000-0002-5741-0399

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Carcinoma, Non-Small-Cell LungLung NeoplasmsAntibodies, MonoclonalBiomarkersChemoradiotherapyHumansAntibodies, MonoclonalBiomarkersdurvalumabImmunotherapyTumor Biomarkers

Identifiers

PMID35640931
PMCPMC9157364

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.